Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile.
Open | $6.71 |
Close | - |
Volume / Avg. | 22.32K / 17.66K |
Day Range | $6.38 - $6.89 |
52 Wk Range | 6.05 - 36.00 |
Market Cap | $222.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 1.34% |
Days to Cover | 2.38 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.
Other companies in Purple Biotech’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).
Purple Biotech has a consensus price target of $15.75.
The stock price for Purple Biotech (NASDAQ: PPBT) is $6.555 last updated September 23, 2024 at 1:41 PM EDT.
There are no upcoming dividends for Purple Biotech.
Purple Biotech’s Q3 earnings are confirmed for Tuesday, November 19, 2024.
There is no upcoming split for Purple Biotech.
Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.